Calamos Advisors LLC raised its position in shares of Cardinal Health Inc. (NYSE:CAH) by 0.0% during the second quarter, Holdings Channel reports. The institutional investor owned 39,955 shares of the company’s stock after buying an additional 13 shares during the period. Calamos Advisors LLC’s holdings in Cardinal Health were worth $3,117,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Acrospire Investment Management LLC purchased a new position in shares of Cardinal Health during the first quarter valued at approximately $107,000. Integrated Investment Consultants LLC increased its position in shares of Cardinal Health by 15.4% in the second quarter. Integrated Investment Consultants LLC now owns 1,459 shares of the company’s stock valued at $114,000 after buying an additional 195 shares during the period. JFS Wealth Advisors LLC increased its position in shares of Cardinal Health by 8,281.0% in the second quarter. JFS Wealth Advisors LLC now owns 1,760 shares of the company’s stock valued at $137,000 after buying an additional 1,739 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in shares of Cardinal Health by 27.2% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,480 shares of the company’s stock valued at $193,000 after buying an additional 530 shares during the period. Finally, Copper Rock Capital Partners LLC purchased a new position in shares of Cardinal Health during the second quarter valued at approximately $205,000. Institutional investors and hedge funds own 85.79% of the company’s stock.
Cardinal Health Inc. (NYSE:CAH) traded up 1.04% during trading on Friday, reaching $77.70. 2,614,015 shares of the company’s stock were exchanged. The stock’s 50 day moving average price is $79.42 and its 200 day moving average price is $80.34. Cardinal Health Inc. has a 52-week low of $73.25 and a 52-week high of $91.23. The firm has a market cap of $24.75 billion, a P/E ratio of 17.99 and a beta of 0.59.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $1.14 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.01. The company had revenue of $31.40 billion for the quarter, compared to analyst estimates of $31.06 billion. Cardinal Health had a net margin of 1.17% and a return on equity of 26.09%. The company’s revenue was up 13.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.00 earnings per share. Equities research analysts anticipate that Cardinal Health Inc. will post $5.59 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Saturday, October 15th. Stockholders of record on Monday, October 3rd will be given a $0.4489 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Thursday, September 29th. Cardinal Health’s payout ratio is presently 41.67%.
CAH has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, July 8th. Morgan Stanley reiterated a “hold” rating and issued a $91.00 target price on shares of Cardinal Health in a report on Monday, September 12th. FBR & Co reiterated a “buy” rating on shares of Cardinal Health in a report on Monday, June 20th. Bank of America Corp. reiterated a “neutral” rating and issued a $83.00 target price on shares of Cardinal Health in a report on Tuesday, June 7th. Finally, Leerink Swann restated an “outperform” rating and issued a $92.00 price target on shares of Cardinal Health in a research report on Monday, June 20th. Eight investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $94.76.
In other news, SVP Stuart G. Laws sold 9,703 shares of the stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $82.45, for a total value of $800,012.35. Following the transaction, the senior vice president now directly owns 2,718 shares of the company’s stock, valued at $224,099.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Donald M. Jr. Casey sold 59,180 shares of the stock in a transaction dated Wednesday, August 10th. The shares were sold at an average price of $83.59, for a total transaction of $4,946,856.20. Following the completion of the transaction, the chief executive officer now directly owns 164,803 shares in the company, valued at $13,775,882.77. The disclosure for this sale can be found here. 0.94% of the stock is currently owned by insiders.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc. (NYSE:CAH).
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.